US1374041093 - Common Stock
CANDEL THERAPEUTICS INC
NASDAQ:CADL (6/13/2024, 8:11:43 PM)
After market: 7.51 -0.03 (-0.4%)7.54
-0.04 (-0.53%)
Candel Therapeutics, Inc. is a late clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. The company is headquartered in Needham, Massachusetts and currently employs 76 full-time employees. The company went IPO on 2021-07-27. The firm is focused on helping patients fight cancer with oncolytic viral immunotherapies. Its engineered viruses are designed to induce immunogenic death through viral-mediated cytotoxicity in cancer cells, therefore releasing tumor neo-antigens and creating a pro-inflammatory microenvironment at the site of injection. The firm has two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus, and herpes simplex virus (HSV) constructs, respectively. Its two product candidates include CAN-2409 and CAN-3110. CAN-2409 is an adenovirus-based, replication-deficient engineered gene construct encoding the thymidine kinase gene derived from the herpes simplex virus. Its enLIGHTEN Discovery Platform is the systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors.
CANDEL THERAPEUTICS INC
117 Kendrick Street,, Suite 450
Needham MASSACHUSETTS
P: 16179165445
CEO: Paul Peter Tak
Employees: 76
Website: https://www.candeltx.com/
/PRNewswire/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation...
/CNW/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may...
NEEDHAM, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical...
By Jeremy Golden, Benzinga
Here you can normally see the latest stock twits on CADL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: